Literature DB >> 8674412

Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation.

C M Alexander1, E J Hansell, O Behrendtsen, M L Flannery, N S Kishnani, S P Hawkes, Z Werb.   

Abstract

Gelatinase B, a matrix metalloproteinase (MMP) of high specific activity, is highly expressed and activated by mouse blastocysts in culture, and inhibition of this enzyme activity inhibits lysis of extracellular matrix (Behrendtsen, O., Alexander, C. M. and Werb, Z. (1992) Development 114, 447-456). Because gelatinase B expression is linked to invasive potential, we studied the expression of gelatinase B mRNA and protein in vivo, in implanting trophoblast giant cells, and found that it was expressed and activated during colonization of the maternal decidua. mRNAs for several other MMPs (stromelysin-1, stromelysin-3 and gelatinase A) and MMP inhibitors (TIMP-1 and TIMP-2) were expressed in the undifferentiated stroma toward the outside of the decidua, and TIMP-3 mRNA was expressed in primary and some mature decidual cells during their differentiation. Both mRNA and TIMP-3 protein were present at high concentrations transiently, and declined from 6.5 days post coitum onward, as the cells underwent apoptosis during the main period of gelatinase B expression and ectoplacental growth and expansion. To assess the function of MMPs during implantation and decidual development, we either injected a peptide hydroxamate MMP inhibitor into normal mice or studied transgenic mice overexpressing TIMP-1. In both cases, decidual length and overall size were reduced, and the embryo was displaced mesometrially. Embryo orientation was less strictly regulated in inhibitor-treated deciduae than in control deciduae. Morphogenesis and development of oil-induced deciduomas were also slowed in the presence of the inhibitor. We conclude that administration of MMP inhibitors retards decidual remodeling and growth, and we suggest that the MMPs expressed in precursor stromal cells promote their differentiation and expansion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674412     DOI: 10.1242/dev.122.6.1723

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  69 in total

1.  Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.

Authors:  C Vaillant; M Didier-Bazès; A Hutter; M F Belin; N Thomasset
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 3.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 4.  The evolution of embryo implantation.

Authors:  Michael R McGowen; Offer Erez; Roberto Romero; Derek E Wildman
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

5.  Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells.

Authors:  A MacAuley; J C Cross; Z Werb
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

6.  MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.

Authors:  Bao Song; Chuanxi Wang; Jie Liu; Xingwu Wang; Liyan Lv; Ling Wei; Li Xie; Yan Zheng; Xianrang Song
Journal:  J Exp Clin Cancer Res       Date:  2010-03-27

7.  Cross-species transcriptomic approach reveals genes in hamster implantation sites.

Authors:  Wei Lei; Jennifer Herington; Cristi L Galindo; Tianbing Ding; Naoko Brown; Jeff Reese; Bibhash C Paria
Journal:  Reproduction       Date:  2014-09-24       Impact factor: 3.906

8.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

Review 9.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

10.  MMP9 is protective against lethal inflammatory mass lesions in the mouse colon.

Authors:  Andreas Hald; Birgitte Rønø; Maria C Melander; Ming Ding; Susanne Holck; Leif R Lund
Journal:  Dis Model Mech       Date:  2010-12-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.